A medication assessment tool to evaluate prescribers’ adherence to evidence-based guidelines in bipolar disorder
- 234 Downloads
Background The goal of evidence-based clinical practice has led to an increased interest in the development of tools to measure adherence to national guidelines in different diseases. This aids in detecting and measuring inappropriate prescribing to specific patient groups by using quality standards extracted from evidence-based guidelines, and ultimately provide the basis of consistent standardized prescribing. Objective To design and validate a medication assessment tool to assess prescribers’ adherence to international guideline recommendations in the management of bipolar disorder (MATBD). Setting Outpatient psychiatry clinic at a secondary healthcare setting in Kuwait. Method International guidelines concerned with the management of bipolar disorder were reviewed in order to develop MATBD. Face and content validity of the developed tool (MATBD) was performed with a research and expert group. A 4-point Likert scale was used to assess the expert group’s level of agreement to individual criterion. Content validity ratio (CVR) was calculated for each criterion (n = 54) and the content validity index (CVI) was calculated for each section (n = 5) of the MATBD. Finally, feasibility testing was performed on 19 patient records to confirm the tool’s fitness for purpose. Main Outcomes Measure Perceived relevance, utility, and clarity of individual criteria, and reliability of their application to clinical settings. Results Face validity and content validity were achieved with a research and expert group (n = 14). Content validity ratio (CVR) was demonstrated for 54 criteria; criteria with a negative CVR were removed. This resulted in a draft MATBD comprising of 52 criteria (CVI: 0.814). Feasibility testing on 19 patients’ records resulted in a final MATBD comprising of 49 criteria divided into 3 sections: initial assessment, acute management and monitoring. Conclusion A medication assessment tool was developed and validated to be used as a means of profiling potential opportunities for medication therapy management optimization, and improving therapeutic interventions regarding the management of bipolar disorder.
KeywordsBipolar disorder Clinical guidelines Guideline adherence Kuwait Medication therapy management
The authors thank Bashayer Al Khobaizi, BPharm (Ministry of Health, Kuwait) and Zahraa Al Tabtabtaie, BPharm (Ministry of Health, Kuwait) for their assistance in data collection and managing the subjects. Special thanks is due to Shaimaa Abdelmeguid, MSc (Faculty of Pharmacy, Kuwait University) for her technical assistance throughout the study.
This study was funded by Kuwait University, grant number ZP03/14.
Conflicts of interest
All authors declare that they have no conflicts of interest.
- 1.Department of Health. High quality care for all–NHS Next stage review final report. 2008 UK.Google Scholar
- 2.President’s advisory commission on consumer protection and quality in the health care industry. Quality first: better health care for all Americans—final report to the President of the United States. 1998 Washington, Government Printing Office.Google Scholar
- 9.Dawda Y. Bipolar affective disorder: long-term management.Clinical pharmacist. 2009:73–82.Google Scholar
- 10.Drayton SJ, Pelic CM. Bipolar Disorder. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach, 9e. New York: The McGraw-Hill Companies; 2014. Chapter 52.Google Scholar
- 15.Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML, et al. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med. 2005;35:1695–706.Google Scholar
- 16.Suppes T, Rush AJ, Dennehy EB, Crismon ML, Kashner TM, Toprac MG, et al. Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry. 2003;64:370–82.Google Scholar
- 17.Wang Z, Gao K, Hong W, Xing M, Wu Z, Chen J, et al. Guidelines disconcordance in acute bipolar depression: data from the National Bipolar Mania Pathway Survey (BIPAS) in mainland China. PLoS ONE. 2014. doi: 10.1371/journal.pone.0096096.
- 22.Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:1–44.Google Scholar
- 23.National institute for health and care excellence. Bipolar disorder: assessment and management. Clinical guideline [CG185]; 2014; Updated Feb 2016.Google Scholar